MYH9, myosin heavy chain 9, 4627

N. diseases: 196; N. variants: 38
Disease: Diabetic end stage renal disease ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0854078
Disease: Diabetic end stage renal disease
Diabetic end stage renal disease 		0.040 GeneticVariation disease BEFREE Though single nucleotide polymorphisms (SNPs) in the non-muscle myosin gene (MYH9) have been reported to explain most of the excess risk of nondiabetic chronic kidney disease (CKD), in African-Americans, some studies have also shown associations with diabetic end-stage renal disease. 23285077 2012
CUI: C0854078
Disease: Diabetic end stage renal disease
Diabetic end stage renal disease 		0.040 GeneticVariation disease BEFREE Polymorphisms in the non-muscle myosin IIA gene (MYH9) are associated with focal segmental glomerulosclerosis (FSGS) and non-diabetic end-stage renal disease (ESRD) in African Americans and FSGS in European Americans. 21968013 2012
CUI: C0854078
Disease: Diabetic end stage renal disease
Diabetic end stage renal disease 		0.040 GeneticVariation disease BEFREE Single nucleotide polymorphisms (SNPs) in MYH9 and APOL1 on chromosome 22 (c22) are powerfully associated with non-diabetic end-stage renal disease (ESRD) in African Americans (AAs). 21698141 2011
CUI: C0854078
Disease: Diabetic end stage renal disease
Diabetic end stage renal disease 		0.040 GeneticVariation disease BEFREE Genetic variation at the MYH9 locus is linked to the high incidence of focal segmental glomerulosclerosis (FSGS) and non-diabetic end-stage renal disease among African Americans. 20668430 2010